Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency
Zhongchao Inc., a platform-based internet technology company offering services to patients with oncology and other major diseases, announced that its MDMOOC Platform will apply the ChatGPT (Chat Generative Pre-trained Transformer) to provide assistance for physicians in clinical decision-making to improve the efficiency of diagnosis and treatment. This is an expanded application of ChatGPT by Zhongchao since its initial application of ChatGPT to elevate patient management service capabilities and experience.
The application of ChatGPT will be available on the MDMOOC ChatGPT Wechat Public Account (“MDMOOC ChatGPT”), a public account on WeChat. Physicians can utilize MDMOOC ChatGPT to access the latest information on diseases, diagnostic criteria, treatment options, research data, and guidelines. In addition, physicians will be alerted that contents provided by ChatGPT will be solely for reference and convenience to users and shall not be relied on for diagnostic or treatment purposes. The application of ChatGPT will allow physicians to quickly comprehend multidisciplinary knowledge and clinical data as needed in developing comprehensive and up-to-date treatment plans for individual patients.
Recommended AI: Millennium Physician Group and Navina Release Value-Based Results of Technology Implementation
Given sheer volume and complexity of medical information, and numerous disease types, the potential for multiple health issues in a single patient, and the need for a more nuanced approach to patient treatment solution among multiple treatment options, physicians must consider a wide range of factors, including the latest evidence-based recommendations, the patient’s unique medical history, and their own clinical experience which requires a deep understanding of medical knowledge and advanced clinical thinking skills. Zhongchao believes that applying ChatGPT to support clinical diagnosis and treatment decisions will improve the efficiency of these processes. In particular, this approach will bridge the knowledge gap and reduce the disparity among physicians regardless of locations, facilities and supports they possess. In addition, MDMOOC ChatGPT can contribute in research, such as generating research outlines and pinpointing relevant research topics. Zhongchao plans to continue leveraging the advanced thinking and computing capabilities of ChatGPT in its other platforms and businesses to offer innovative and convenient services and experiences to both physicians and patients alike.
Recommended AI: Stability AI Partners With Krikey AI to Launch AI Animation Tools
To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.